AMS Newsletter April 2024

In this edition

• Menopause Down Under, Sydney | recording now available for review
• Climacteric status and participation in working life
• IMS World Congress on Menopause in Melbourne 2024

Health Professionals - join AMS for Members-only content 

• Menopause Matters
• Obesity and menopause: Is there anything new in menopause medicine?
• Non-Hormonal Pharmacological Interventions For VMS - IMS webinar online now
• Climacteric E-alert - Vol 27 Iss 2 April 2024
• Our Menopause World April 2024
• European Menopause and Andropause Society (EMAS) Newsletter

In this edition

Menopause Down Under, Sydney | recording now available for review

At Rydges World Square, Sydney on Saturday 6 April 2024, AMS hosted Menopause Down Under.

This whole day event conecentrated on midlife women's health issues including the fundamentals of menopause medicine, management of bleeding whilst on menopausal hormonal therapy, pelvic floor dysfunction and incontinence, and management of genitourinary syndrome of the menopause.

There was also a panel discussion on managing complex cases.

The event is available for reviewing now by registering. 

Note: AMS will not be issuing RACGP CPD points for watching the recording. 

Registration for review

	AMS members	General Admission
Online	$20	$59

Register here

Menopause Down Under

Program

See Program and information on Speakers online here

Climacteric status and participation in working life

Since most women will continue working for years after entering menopause, the effect of menopause symptoms on their working ability is an important issue and the focus of a new study. Among other things, the study suggested that premature menopause can limit a woman’s work ability and time spent in the workforce. 

Early menopause is the term used when women undergo menopause early—before the age of 45 years. Approximately 5% to 10% of all women fit into this category. At this point, it is assumed that women have almost 20 years of their working life remaining. However, the menopause transition causes roughly 80% of women to suffer from such bothersome symptoms as hot flashes and night sweats, which can adversely affect a woman’s quality of life.

Menopause (estrogen deficiency) can take a toll on women’s health in other ways as well, including an increased risk of cardiovascular disease and osteoporosis, unfavorable changes in body composition, and musculoskeletal pain. To date, however, few studies have analyzed whether menopause symptoms may be negatively associated with work ability and well-being at work.

A previous UK study showed that menopause before 45 years of age was associated with a ninepercentage-point reduction in labor market participation once these women entered their 50s compared with women who did not experience early menopause.

In this latest study that involved nearly 2,700 Finnish women, researchers investigated how women’s menopause status at 46 years of age was associated with their perceived work ability and registered working life participation during subsequent years. It concluded that an early menopause transition is challenging in that it affects women’s work ability and limits their working life participation.

Based on these results, the researchers recommend that healthcare professionals effectively treat menopause symptoms and promote the overall health of women experiencing early onset menopause so that they continue to be productive in the workforce. Further, they suggest that employers consider making working conditions more flexible for women undergoing the menopause transition to help them manage their symptoms to limit the risk of them prematurely ending their careers.

Read more

IMS World Congress on Menopause in Melbourne 2024

Registrations are now open for the IMS World Congress in Melbourne this October. AMS members have access to the same discounted IMS member rate for the IMS World Congress on Menopause in Melbourne, 19-22 October 2024.

Registration for Australian and New Zealand trainees is FREE until 23 September 2024.

We look forward to welcoming you to the IMS World Congress on Menopause.

 Health Professionals - join AMS for Members-only content 

Menopause Matters: Professor Athol Kent has reviewed and summarised this month’s journals.

IMS Live 15 April 2024: Obesity and menopause: Is there anything new in menopause medicine?

Palacios et al. recently published a review on obesity and menopause [1]. Obesity is a clear-cut, worldwide, very common health problem which relates to increased incidence of various diseases, mainly cardiovascular. The paper summarizes the relevant literature until the end of 2023. As an introduction, the authors write that "obesity is associated with menstrual cycle alterations (e.g. anovulatory cycles ending with abnormal uterine bleeding), menopausal symptoms including hot flashes, poor sleep, aches and joint pain, urinary symptoms, and reduced quality of life"... 

Non-pharmacological Interventions for VMS - IMS webinar online now
Moderator: Professor Peter Schnatz

Climacteric E-alert - Vol 27 Iss 2 April 2024  See a copy of the April alert  

Our Menopause World - See a copy of OMW April 2024

European Menopause and Andropause Society (EMAS) Newsletter AMS is an affiliate of EMAS. See latest copy.